These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 21280612)

  • 21. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug.
    Okudaira N; Tatebayashi T; Speirs GC; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Aug; 294(2):580-7. PubMed ID: 10900235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.
    Landowski CP; Song X; Lorenzi PL; Hilfinger JM; Amidon GL
    Pharm Res; 2005 Sep; 22(9):1510-8. PubMed ID: 16132363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
    Anderson BD; Morgan ME; Singhal D
    Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
    Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
    J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of valacyclovir: implications for its oral bioavailability.
    Granero GE; Amidon GL
    Int J Pharm; 2006 Jul; 317(1):14-8. PubMed ID: 16759825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs.
    Yuan H; Li N; Lai Y
    Drug Metab Dispos; 2009 Jul; 37(7):1443-7. PubMed ID: 19372225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats.
    Høyem S; Bruheim S; Maelandsmo G; Olberg DE; Brudeli B; Asberg A; Klaveness J; Rongved P
    Eur J Med Chem; 2009 Oct; 44(10):3874-9. PubMed ID: 19433342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
    Wang W; Liu Q; Wang C; Meng Q; Kaku T; Liu K
    Peptides; 2011 May; 32(5):946-55. PubMed ID: 21310202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
    de Vrueh RL; Smith PL; Lee CP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1166-70. PubMed ID: 9732374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
    Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
    Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal dipeptide absorption is preserved during thermal injury and cytokine treatment.
    Foster DR; Gonzales JP; Amidon GL; Welage LS
    JPEN J Parenter Enteral Nutr; 2009; 33(5):520-8. PubMed ID: 19443858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic insights into PEPT1-mediated transport of a novel antiepileptic, NP-647.
    Khomane KS; Nandekar PP; Wahlang B; Bagul P; Shaikh N; Pawar YB; Meena CL; Sangamwar AT; Jain R; Tikoo K; Bansal AK
    Mol Pharm; 2012 Sep; 9(9):2458-68. PubMed ID: 22779445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary.
    Skanji R; Andrieux K; Lalanne M; Caron J; Bourgaux C; Degrouard J; Brisset F; Gueutin C; Chacun H; Dereuddre-Bosquet N; Paci A; Vassal G; Bauduin L; Garcia-Argote S; Rousseau B; Clayette P; Desmaële D; Couvreur P
    Int J Pharm; 2011 Jul; 414(1-2):285-97. PubMed ID: 21596125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous determination of didanosine and its amino acid prodrug, valdidanosine by hydrophilic interaction chromatography coupled with electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study in rats.
    Yan Z; Sun J; Wang J; Xu Y; Chang Y; Meng P; Zhu M; Fu Q; Sun Y; He Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):466-70. PubMed ID: 20022566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
    Jain R; Agarwal S; Majumdar S; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2005 Oct; 303(1-2):8-19. PubMed ID: 16137847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.
    Shanmuganathan K; Koudriakova T; Nampalli S; Du J; Gallo JM; Schinazi RF; Chu CK
    J Med Chem; 1994 Mar; 37(6):821-7. PubMed ID: 8145233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactivatable Pseudotripeptidization of Cyclic Dipeptides To Increase the Affinity toward Oligopeptide Transporter 1 for Enhanced Oral Absorption: An Application to Cyclo(l-Hyp-l-Ser) (JBP485).
    Jiang Q; Zhang J; Tong P; Gao Y; Lv Y; Wang C; Luo M; Sun M; Wang J; Feng Y; Cao L; Wang G; Wang Y; Kan Q; Zhang T; Wang Y; Liu K; Sun J; He Z
    J Med Chem; 2019 Sep; 62(17):7708-7721. PubMed ID: 31393124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
    Choi JS; Shin SC
    Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.